Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 20, 2021

SELL
$28.4 - $36.14 $575,952 - $732,919
-20,280 Closed
0 $0
Q4 2020

Jan 27, 2021

SELL
$23.69 - $31.47 $395,599 - $525,517
-16,699 Reduced 45.16%
20,280 $589,000
Q3 2020

Oct 19, 2020

SELL
$26.38 - $33.1 $68,588 - $86,060
-2,600 Reduced 6.57%
36,979 $1.04 Million
Q2 2020

Jul 29, 2020

SELL
$29.93 - $50.1 $29,930 - $50,100
-1,000 Reduced 2.46%
39,579 $1.28 Million
Q1 2020

Apr 17, 2020

SELL
$30.35 - $67.14 $22,762 - $50,355
-750 Reduced 1.81%
40,579 $1.65 Million
Q4 2019

Jan 30, 2020

BUY
$55.65 - $79.83 $92,935 - $133,316
1,670 Added 4.21%
41,329 $2.55 Million
Q3 2019

Oct 17, 2019

BUY
$64.7 - $85.39 $42,055 - $55,503
650 Added 1.67%
39,659 $2.89 Million
Q2 2019

Jul 15, 2019

SELL
$67.77 - $82.2 $273,113 - $331,266
-4,030 Reduced 9.36%
39,009 $3.21 Million
Q1 2019

Apr 22, 2019

SELL
$45.83 - $70.54 $197,069 - $303,322
-4,300 Reduced 9.08%
43,039 $3.04 Million
Q4 2018

Jan 22, 2019

BUY
$41.17 - $56.44 $37,053 - $50,796
900 Added 1.94%
47,339 $2.13 Million
Q3 2018

Oct 22, 2018

BUY
$52.95 - $71.34 $353,441 - $476,194
6,675 Added 16.79%
46,439 $2.63 Million
Q2 2018

Jul 16, 2018

BUY
$56.38 - $68.08 $214,187 - $258,635
3,799 Added 10.56%
39,764 $2.66 Million
Q1 2018

Apr 24, 2018

BUY
$56.98 - $72.41 $168,945 - $214,695
2,965 Added 8.98%
35,965 $2.09 Million
Q4 2017

Jan 26, 2018

BUY
$53.3 - $74.56 $295,815 - $413,808
5,550 Added 20.22%
33,000 $2.13 Million
Q3 2017

Oct 12, 2017

BUY
$43.46 - $52.49 $1.19 Million - $1.44 Million
27,450
27,450 $1.44 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.03B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Regent Investment Management LLC Portfolio

Follow Regent Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Investment Management LLC with notifications on news.